Purchase Order 75N92E25P00190

<p>The National Human Genome Research Institute, a civilian government agency, awarded a $14,706.15 firm fixed price purchase order contract to Ons Bio LLC for peptide synthesis services. The contract has an ultimate completion date of April 1, 2025 and does not utilize a set-aside designation. As the National Human Genome Research Institute is a component of the National Institutes of Health, this contract likely supports the agency's research mission in genomics and related fields.</p>

This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to SBH Sciences Inc. on June 12, 2018. The contract has a ceiling value of $8,300 and an ultimate completion date of August 31, 2020. The contract is not designated as a set-aside. Based on the information provided, this award appears to be for a specific product or service required by NHGRI, which is the lead National Institutes of Health (NIH) institute responsible...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc. for $0.00. The contract has no set-aside designation and calls for delivery of products or services by June 11, 2020 in support of the agency's genome research efforts. As the leading federal funder and coordinator of genome research, this contract likely provides the Institute with nanopore sequencing...

The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,613.88 firm fixed price delivery order to Illumina, Inc. under contract number QTE# 00015178.1. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is July 31, 2023 for genomic sequencing and analysis services to support the Institute's research efforts aimed at advancing the understanding of the human...

This firm fixed-price delivery order was awarded to Illumina, Inc. by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian agency. The $9,909.50 contract is not set-aside and provides for the delivery of Illumina's proprietary sequencing systems, reagents, and associated services to support genomic sequencing and analysis research at NHGRI. Illumina has a history of providing similar goods and services to other federal...

This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Illumina, Inc. for $16,447.05. The contract is for the provision of reagents needed by NHGRI staff scientists for preparation of PCR-free whole genome libraries and sequencing. The contract has a period of performance through March 31, 2025 and does not have a set-aside designation. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has...

This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $44,187.38 contract is for the provision of Illumina's sequencing systems, reagents, and related consumables and services to support genomic research and analysis activities. The contract has no set-aside designation and is not associated with a larger acquisition vehicle. Illumina, a manufacturer of genetic and...

The U.S. Department of Health and Human Services (HHS) - National Institutes of Health (NIH) awarded a $5,675.00 firm fixed-price purchase order contract to Medgenome Inc., a small business, for genomic sequencing and data services. The contract has an ultimate completion date of June 30, 2025 and was awarded on August 29, 2024. The contract is not set-aside. Medgenome Inc. provides a range of scientific services, primarily in the field of genomics and lab testing, including genomic...

This $20,000 firm fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Golden Helix Inc., a global bioinformatics company that provides genetic data analysis software and services. The contract is for the renewal or provision of licenses to Golden Helix's genomic analysis software platforms, which enable federal researchers to process,...